InsiderClue
← All stocks

Vistagen Therapeutics, Inc.

VTGN Net buying
CIK 0001411685 #5233 in the set updated 22 Sep 2026
Bought (120 mo)
$18.21M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$147.15K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$147.15K
2 of 2 sales
Net
+$18.07M
+$18.07M against sales at will

By person

13 insiders · 28 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
COMMODORE CAPITAL LP entity
10% owner
$17.96M (1)
—
+$17.96M
1,575,000
3.84%
$36.47M
+97.1%
Singh Shawn
President and CEO
$103.20K (1)
—
+$103.20K
733,548
1.79%
$16.98M
—
DOTSON JERROLD DUANE
VP, CFO
—
$93.75K (1)
−$93.75K
3,671
0.0089%
$84.99K
—
Venrock Healthcare Capital Partners II, L.P. entity
10% owner
—
$53.40K (1)
−$53.40K
20,637,286
50.30%
$477.82M
−0.3%
Adler Reid G.
Chief Legal Officer
$50.91K (1)
—
+$50.91K
60,868
0.1483%
$1.41M
—
SAXE JON S
Director
$45.99K (3)
—
+$45.99K
55,751
0.1359%
$1.29M
+2,872%
GIN JERRY B
Director
$35.74K (4)
—
+$35.74K
350,000
0.8530%
$8.10M
+600.0%
SNODGRASS H. RALPH
PRES./CHIEF SCIENTIFIC OFFICER
$15.34K (2)
—
+$15.34K
133,500
0.3254%
$3.09M
+40.7%
Smith Mark Alan
CHIEF MEDICAL OFFICER
—
—
—
19,915
0.0485%
$461.09K
—
Prince Joshua S.
Chief Operating Officer
—
—
—
15,249
0.0372%
$353.06K
—
Anderson Cynthia Lynn
CHIEF FINANCIAL OFFICER
—
—
—
12,801
0.0312%
$296.38K
—
Tressler Nick B.
Chief Financial Officer
—
—
—
11,712
0.0285%
$271.17K
—
Underdown Brian J.
Director
—
—
—
2,500
0.0061%
$57.88K
—

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Singh Shawn
12 May 2022
CHIEF EXECUTIVE OFFICER
Exercised, kept
100,000
$1.00
$100.00K
DOTSON JERROLD DUANE
11 Jan 2022
VP, CFO AND SECRETARY
Exercised, kept
18,750
$1.00
$18.75K
DOTSON JERROLD DUANE
30 Jun 2021
VP, CFO AND SECRETARY
Exercised, kept
9,824
$0.40
$3.91K
DOTSON JERROLD DUANE
30 Jun 2021
VP, CFO AND SECRETARY
Exercised, kept
78,918
$1.00
$78.92K
DOTSON JERROLD DUANE
30 Jun 2021
VP, CFO AND SECRETARY
Exercised, kept
1,000
$1.50
$1.50K
Singh Shawn
23 Apr 2021
CHIEF EXECUTIVE OFFICER
Exercised, kept
5,000
$1.50
$7.50K
SAXE JON S
19 Mar 2021
Director
Exercised, kept
2,500
$1.50
$3.75K
Underdown Brian J.
19 Mar 2021
Director
Exercised, kept
2,500
$1.50
$3.75K
SNODGRASS H. RALPH
13 Mar 2019
PRES./CHIEF SCIENTIFIC OFFICER
Exercised, kept
2,500
$1.50
$3.75K
SAXE JON S
29 Jan 2019
Director
Exercised, kept
1,000
$1.50
$1.50K
SAXE JON S
29 Jan 2019
Director
Exercised, kept
375
$1.50
$562.50
Singh Shawn
14 Jan 2019
CHIEF EXECUTIVE OFFICER
Exercised, kept
3,000
$1.50
$4.50K
Singh Shawn
14 Jan 2019
CHIEF EXECUTIVE OFFICER
Exercised, kept
1,125
$1.50
$1.69K
Singh Shawn
14 Jan 2019
CHIEF EXECUTIVE OFFICER
Exercised, kept
21,250
$1.50
$31.88K
Show all 28 transactions →

What was left out

Form 4 filings counted 190
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 2
Shares from compensation/vesting 480,787
Sales filed before the plan box existed 2
History held since 10 Nov 2016